헬스케어 3D 프린팅 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2024-2032년)

The Global Healthcare 3D Printing Market was valued at USD 2.9 billion in 2023 and is projected to grow at a CAGR of 18.6% from 2024 to 2032. This growth is largely driven by increased research and development investments from manufacturers and institutions, along with a broadening array of clinical applications. The expanding use of 3D printing technology in clinical settings is a major factor contributing to market growth. This innovative approach allows the creation of highly customized medical devices, including implants, prosthetics, and surgical instruments tailored specifically to meet the anatomical needs of individual patients. Such customization significantly enhances treatment outcomes.

Additionally, 3D printing is being utilized to produce accurate anatomical models that aid in surgical planning, reducing the likelihood of errors and improving precision during procedures. The market is segmented by product types, including inkjet-based, syringe-based, laser-based, and magnetic levitation technologies. The syringe-based segment generated around USD 1.2 billion in revenue in 2023. These systems are particularly advantageous in bioprinting applications, where tissues and organs are crafted using bio-inks that contain living cells. The precision and control of syringe-based systems make them highly suitable for healthcare environments, especially in research and regenerative medicine.

Their versatility in managing various materials, such as hydrogels and bio-inks, further cements their role in tissue engineering and drug testing. When examining applications, the healthcare 3D printing market encompasses the medical, dental, and biosensor sectors. The medical applications segment is projected to yield the highest revenue of USD 6.8 billion during the forecast period. This segment covers essential areas such as orthopedics and cardiovascular implants, making it a focal point for healthcare providers and researchers.

The advancements in medical 3D printing technology allow the production of personalized medical devices and implants that cater to the unique anatomical needs of patients, significantly enhancing treatment efficacy and overall patient care. North America holds a substantial share of the healthcare 3D printing market, generating USD 1.1 billion in revenue in 2023. This region is expected to experience a CAGR of 18% from 2024 to 2032. The embrace of advanced medical devices and personalized treatment options has been pivotal in propelling the growth of 3D printing within healthcare. The ongoing innovations in bioprinting and 3D-printed medical devices, backed by significant government funding, are being spearheaded by leading healthcare institutions and universities in North America.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Technological advancements
    • 3.2.1.2 Extended clinical applications
    • 3.2.1.3 Rising demand for custom implants
    • 3.2.1.4 Increasing R&D investments from manufacturers and institutions
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Lack of skilled professionals
    • 3.2.2.2 High price associated with 3D printing
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Pricing analysis, by product, 2023
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends
• 3.11 Gap analysis
• 3.12 Value-chain analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Syringe based
• 5.3 Inkjet based
• 5.4 Laser based
• 5.5 Magnetic levitation

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Fused deposition modelling (FDM)
• 6.3 Selective laser sintering (SLS)
• 6.4 Stereolithography
• 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Medical
  • 7.2.1 Pharmaceuticals
  • 7.2.2 Prosthetics and implants
  • 7.2.3 Tissue and organ generation
• 7.3 Dental
• 7.4 Biosensors

Chapter 8 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Polymers
• 8.3 Metals and alloys
• 8.4 Biological materials
• 8.5 Other materials

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 3D Biotek
• 10.2 3D Systems
• 10.3 Aprecia Pharmaceuticals
• 10.4 Aspect Biosystems
• 10.5 Cyfuse Biomedical
• 10.6 Dassault Systemes
• 10.7 Envision TEC
• 10.8 Materialise
• 10.9 Metamorph 3D print services
• 10.10 Nano3D Biosciences
• 10.11 Oceanz
• 10.12 REGENHU
• 10.13 Renishaw
• 10.14 Stratasys
• 10.15 Xometry